|
Related Party Transactions
|
6 Months Ended | ||||
|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||
| Related Party Transactions [Abstract] | |||||
| Related Party Transactions Disclosure [Text Block] |
In January 2012, the Company entered into an agreement with Novici Biotech, LLC (“Novici”) in which iBio’s President is a minority stockholder. Novici performs laboratory feasibility analyses of gene expression, protein purification and preparation of research samples. The accounts payable balance includes amounts due to Novici of approximately $75,000 and $38,000 at December 31, 2014 and June 30, 2014, respectively. Research and development expenses related to Novici were approximately $258,000 and $153,000 for the three months ended December 31, 2014 and 2013, respectively, and approximately $480,000 and $306,000 for the six months ended December 31, 2014 and 2013, respectively. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|